Sleep apnea device maker ResMed agrees to sell its software business MatrixCare to PE firm Frazier for $490M in cash; ResMed bought MatrixCare for $750M in 2018
ResMed (RMD.N) said on Tuesday it would sell its software business MatrixCare to private equity firm Frazier Healthcare Partners...